Product Information

LYRICA 75 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $9.6749 per EA under NDC 00071101468. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LYRICA 75 MG CAPSULE

PREGABALIN
$9.6749per EA
Discontinued
High Outlier
DEA Schedule CV

Strength

75 mg/1

Manufacturer

Pfizer Inc.

NDC

00071101468

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PREGABALIN

Approval Type

New Drug (NDA)

FDA Application

NDA021446

On Market Since

12/30/2004

Price Statistics

The NADAC for LYRICA 75 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 169.1%. The table below summarizes its recorded NADAC range and movement.

Current price$9.6749 per EA
All-time high$9.7419 (Nov 12, 2025)
All-time low$3.5959 (Nov 28, 2013)
52-week high$9.7419
52-week low$9.6749
Median price$7.8468
Average price$7.4701
Largest weekly change+9.4% (Jun 11, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.0%

3M

-0.6%

6M

-0.5%

1Y

-0.6%

3Y

+4.8%

5Y

+17.6%

All

+169.1%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LYRICA 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LYRICA 75 MG CAPSULE, manufactured by Pfizer Inc., is $9.6749 per EA (NDC 00071101468), effective Jun 24, 2026.

How has the price of LYRICA 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LYRICA 75 MG CAPSULE has risen 169.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LYRICA 75 MG CAPSULE?

Since Nov 28, 2013, the NADAC for LYRICA 75 MG CAPSULE has ranged from a low of $3.5959 (Nov 28, 2013) to a high of $9.7419 (Nov 12, 2025), with a median of $7.8468 per EA.

Are there cheaper alternatives to LYRICA 75 MG CAPSULE?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 75 MG CAPSULE, is $0.0499 per EA — about 99% below LYRICA 75 MG CAPSULE.

Who manufactures LYRICA 75 MG CAPSULE?

LYRICA 75 MG CAPSULE (NDC 00071101468) is labeled by Pfizer Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.